Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor


ABSTRACT: Rocaglamide A (RocA) typifies a class of protein synthesis inhibitors that selectively kill aneuploid tumor cells and repress translation of specific mRNAs. RocA targets eukaryotic initiation factor 4A (eIF4A), an ATP-dependent DEAD-box RNA helicase; its mRNA selectivity is proposed to reflect highly structured 5′ UTRs that depend strongly on eIF4A-mediated unwinding. However, rocaglate treatment may not phenocopy the loss of eIF4A activity, as these drugs actually increase the affinity between eIF4A and RNA. Here, we show that secondary structure in 5′ UTRs is only a minor determinant for RocA selectivity and RocA does not repress translation by reducing eIF4A availability. Rather, in vitro and in cells, RocA specifically clamps eIF4A onto polypurine sequences in an ATP-independent manner. This artificially clamped eIF4A blocks 43S scanning, leading to premature, upstream translation initiation and reducing protein expression from transcripts bearing the RocA-eIF4A target sequence. In elucidating the mechanism of selective translation repression by this lead anti-cancer compound, we provide an example of a drug stabilizing sequence-selective RNA-protein interactions. Bind-n-Seq and iCLIP-Seq

ORGANISM(S): synthetic construct

SUBMITTER: Nicholas Ingolia 

PROVIDER: E-GEOD-79392 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications

Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor.

Iwasaki Shintaro S   Floor Stephen N SN   Ingolia Nicholas T NT  

Nature 20160615 7608


Rocaglamide A (RocA) typifies a class of protein synthesis inhibitors that selectively kill aneuploid tumour cells and repress translation of specific messenger RNAs. RocA targets eukaryotic initiation factor 4A (eIF4A), an ATP-dependent DEAD-box RNA helicase; its messenger RNA selectivity is proposed to reflect highly structured 5' untranslated regions that depend strongly on eIF4A-mediated unwinding. However, rocaglate treatment may not phenocopy the loss of eIF4A activity, as these drugs actu  ...[more]

Similar Datasets

2016-06-15 | GSE79392 | GEO
2016-06-15 | E-GEOD-70211 | biostudies-arrayexpress
2016-06-15 | GSE70211 | GEO
2016-03-14 | E-GEOD-77033 | biostudies-arrayexpress
2018-12-30 | GSE102720 | GEO
2024-07-08 | GSE243312 | GEO
2022-12-17 | GSE201364 | GEO
2015-03-02 | E-GEOD-66411 | biostudies-arrayexpress
2023-10-03 | GSE244093 | GEO
2015-03-02 | GSE66411 | GEO